Startup Spotlight: UNC-linked startup is giving hope to those with hemophilia
GeneVentiv Therapeutics is developing the first universal gene therapy for all types of hemophilia, including the most difficult cases. Let’s take a look.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
